Part 2: Regulatory Challenges With Data Collection
In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…
Certara2024 年 10 月 31 日
Part 1: Complexities in Data Collection
In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…
Certara2024 年 10 月 31 日
Mathematical Modeling and the Monkey King: Use of Modeling for More Efficient NHP Study Design
Background Monkeys and humans share a strong bond, reflected not only in a shared genetic…
Certara2024 年 10 月 30 日
Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women
The article titled "Using PBPK modeling to supplement clinical data and support the safe and…
Certara2024 年 10 月 30 日
The Complete Guide to CDISC Standards Management
Learn how to easily manage and validate against CDISC data standards our complete guide to…
Certara2024 年 10 月 30 日
Certara Announces New Head of Clinical Pharmacology & Translational Medical Group
RADNOR, PA – 2024 年 10 月 30 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2024 年 10 月 30 日
Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment
摘要：T cell interaction in the tumor microenvironment is a key component of immuno-oncology therapy.…
Certara2024 年 10 月 29 日
Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions
Early Feasibility Assessment (EFA) can impact early drug discovery decisions such as determining feasibility of…
Certara2024 年 10 月 29 日
Certara to Participate in the Stephens Annual Investment Conference
RADNOR, Pa. — 2024 年 10 月 28 日 -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2024 年 10 月 28 日
Pharma Exec: MDMA Therapy for Mental Health Conditions
Certara's Dr. Fran Brown, SVP Drug Development Science, is featured in this recent Pharmaceutical Executive…
Certara2024 年 10 月 28 日
